Robotic interval debulking surgery for advanced epithelial ovarian cancer: current challenge or future direction? A systematic review

Psomiadou, Victoria; Prodromidou, Anastasia; Fotiou, Alexandros; Lekka, Sofia; Iavazzo, Christos

doi:10.1007/s11701-020-01155-7

Cited by 7 publications

(2 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In 2021 Psomiadou [17] et al performed a systematic review and found that in patients with advanced ovarian cancer after NACT, robotic-assisted laparoscopic IDS offers advantages in terms of operative time, bleeding, length of stay, postoperative complication rates and intermediate open rates, while ensuring that R0 is achieved. Patients who undergo robotic surgery demonstrate survival advantages over the open route.…”

Section: Robotic Surgery In Advanced Ovarian Cancer and Its Progressmentioning

confidence: 99%

Application of robotic surgery in cytoreductive surgery for advanced ovarian cancer

2023

IJFM

View full text Add to dashboard Cite

It has been a hot topic to correctly evaluate the effect of operation mode and operation approach on patient survival. The robotic surgery system has many advantages such as flexible, stable and delicate, which has excellent results in complex surgeries compared with laparoscopic surgery. The robotic surgery has been applied in the stage operation of early ovarian cancer, the debulking surgery of advanced ovarian cancer and the debulking surgery of recurrent ovarian cancer. This review summarizes the application and controversy of minimally invasive surgery in the treatment of advanced ovarian cancer, and focuses on the feasibility and safety of robotic systems.

show abstract

Section: Robotic Surgery In Advanced Ovarian Cancer and Its Progressmentioning

confidence: 99%

Application of robotic surgery in cytoreductive surgery for advanced ovarian cancer

2023

IJFM

View full text Add to dashboard Cite

show abstract

“…However, MIS techniques have been gaining popularity among gynecologists, ensuring advantages such as lower morbidity, shorter hospital stay and minimised postoperative complications compared to laparotomy. Furthermore, the amplification of the surgical field that is achieved in combination with the updated technological equipment that is used provides an enhanced observation of the entire peritoneal cavity, which constitutes the major prognostic factor of a successful CRS [4].…”

Section: Introductionmentioning

confidence: 99%

Is minimal invasive surgical treatment of ovarian cancer plus HIPEC a utopia? A review of the literature

2021

EJGO

View full text Add to dashboard Cite

The purpose of this study is to evaluate the effectiveness and safety of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) approached by minimally invasive surgical (MIS) techniques. We conducted a systematic review of the published relevant studies and evaluated a total of 403 patients, with a median age of 57 years old (20-69). The histology of the patients included 160 (39.7%) patients with pseudomyxoma peritonei, 43 (10.6%) with mesothelioma peritonei, 37 (9.2%) with epithelial ovarian cancer (EOC), 80 (19.8%) with appendiceal cancer and 26 (6.4%) with colon cancer, while the histology of the rest of the patients was not specified in the studies. The median Periotoneal Cancer Index (PCI) was 4 (1-10) and complete cytoreduction (R0) was achieved in 239 patients (60%). 145 (36%) of the patients underwent omentectomy, 37 patients (9.2%) underwent cecum/right colectomy, 41 patients (10.1%) underwent salpingovariectomy, 6 (1.5%) small bowel resection, 28 (6.7%) peritonectomies, in 9 (2.2%) sigmoeidectomy and 107 (26.5%) appendectomy, with a mean operative time of 240 min (90-510). Conversion to laparotomywas performed in 13 (3.2%) cases, while in 32 (7.9%) an intestinal anastomosis or suture was required. The median length of stay was 4.5 days (3-6) and the median follow-up of the patients was 13.5 months (1-72). We concluded that minimal invasive surgery can be considered as an approach in the application of hyperthermic intraperitoneal chemotherapy. Further large studies with higher quality data are warranted to verify our findings.

show abstract

Robotic surgery in ovarian cancer

Gallotta

Certelli

Oliva

et al. 2023

Best Practice & Research Clinical Obstetrics & Gynaecol

View full text Add to dashboard Cite

Robotic interval debulking surgery for advanced epithelial ovarian cancer: current challenge or future direction? A systematic review

Cited by 7 publications

References 27 publications

Application of robotic surgery in cytoreductive surgery for advanced ovarian cancer

Application of robotic surgery in cytoreductive surgery for advanced ovarian cancer

Is minimal invasive surgical treatment of ovarian cancer plus HIPEC a utopia? A review of the literature

Robotic surgery in ovarian cancer

Contact Info

Product

Resources

About